Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Patients With Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial
J Thorac Oncol 2023 Mar 29;[EPub Ahead of Print], T Makharadze, M Gogishvili, T Melkadze, A Baramidze, D Giorgadze, K Penkov, K Laktionov, G Nemsadze, M Nechaeva, I Rozhkova, E Kalinka, S Li, Y Li, M Kaul, RGW Quek, JF Pouliot, F Seebach, I Lowy, G Gullo, P RietschelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.